Identification of mSHMT as a target of arginase in human breast cancer suggests a potential link between arginine and folate metabolism; however, the mechanisms by which mSHMT expression and activity is regulated by Arg II is not known. This evidence concerns the gene SHMT2 and breast carcinoma.